Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

Dirk A. Heerding(South College), Rakesh Kumar(The University of Texas MD Anderson Cancer Center), Tammy J. Clark(South College), Dennis S. Yamashita(South College), N.O. Concha(GlaxoSmithKline (United States)), Elisabeth A. Minthorn(GlaxoSmithKline (United States)), Derek R. Duckett(Moffitt Cancer Center), Louis V. LaFrance(Johnson & Johnson (United States)), Timothy J. Lansing(South College), Joseph W. Venslavsky(South College), Zhihong Lai(South College), Gregory L. Warren(Platelet BioGenesis (United States)), Nelson Rhodes(South College), Randy T. McConnell(South College), Susan L. Strum(South College), Derek J. Eberwein(South College), Dennis T. Takata(South College), Robert A. Copeland(Unknown), Peter J. Tummino(Intarcia Therapeutics (United States)), Anthony E. Choudhry(GlaxoSmithKline (United States)), Mei Li(Soochow University), Igor G. Safonov(South College), Michael D. Schaber(United States Military Academy), Victoria B. Knick(South College), Edgar R. Wood(United States Department of Veterans Affairs), Jack D. Leber(South College), Richard M. Keenan(South College), ShuYun Zhang(South College)

Journal of Medicinal Chemistry

August 23, 2008

Cited by 158

|Journal of Biological Chemistry|1998|3k

|Nature|1999|1.9k

|Nature|2012|1.8k

|Journal of Biological Chemistry|2002|1.4k

|Proceedings of the National Academy of Sciences|2013|864

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase